Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target
Zhang, Y-Jun.; Dong, L-Feng.; Wang, Y-Li.
Yao Xue Xue Bao 41(10): 913-916
2006
ISSN/ISBN: 0513-4870 PMID: 17184105 Document Number: 595863
Document emailed within 1 workday
Related Documents
Qiu, L.; Du, G.; Liu, D.; Zheng, H.; Zeng, H.-S.; Zhou, N.; Yang, X.-Y. 2013: Bradykinin attenuates mechanical stress-induced myocardial hypertrophy through inhibiting the Ca²⁺/ calcineurin pathway Zhonghua Xin Xue Guan Bing Za Zhi 41(4): 315-319Li, L.; Yi, S. 2015: Heart rate reduction is not the therapeutic target in the chronic heart failure therapy Zhonghua Xin Xue Guan Bing Za Zhi 43(3): 197-199
Kamiya, H.; Okumura, K.; Ito, M.; Saburi, Y.; Tomida, T.; Hayashi, K.; Matsui, H.; Hayakawa, T. 2001: Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder Canadian Journal of Cardiology 17(12): 1292-1298
Fu, M.; Zhang, J.; Xu, S.; Pang, Y.; Liu, N.; Tang, C. 2001: Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats Chinese Medical Sciences Journal 16(1): 1-4
Xing, L.; Li, Z. 2015: Angiotensin Ii induced myocardial hypertrophy in neonatal rats could be attenuated by activated κ-opioid receptor via modulating the calcineurin signal pathways Zhonghua Xin Xue Guan Bing Za Zhi 43(3): 254-258
Loyer, X.; Samuel, J.L.; Heymes, C. 2005: Cardiac myocyte neuronal nitric oxide synthase. new therapeutic target in heart failure? Archives des Maladies du Coeur et des Vaisseaux 98(12): 1244-1248
Avantaggiati, M.L. 2013: Cancer metabolism as a therapeutic target: finding the right target(s) in the context of tumor heterogeneity, evolution, and metabolic plasticity Oncology 27(5): 474; 476-477
Wu, S.; Li, J.; Hong, Y.-Q.; Liang, F.-X.; Tang, H.-T.; Liu, J.-M.; Huang, W.; Chen, Z.-B.; Wang, H. 2012: Effects of electroacupuncture at "Neiguan" (PC 6) on p38 MAPK signaling pathway in rats with cardiac hypertrophy Zhongguo Zhen Jiu 32(2): 145-148
Wang, J.-d.; Wang, Q.-s.; Bai, Y.-z.; Kou, D.-q.; Li, X.-r.; Chen, L.; Li, R. 2013: Effects of mammalian-target-of-rapamycin pathway on lapatinib resistance in breast cancer MDA-MB-231 cells Zhonghua Yi Xue Za Zhi 93(24): 1915-1917
Bogdanik, T.; Warmus, M.; Bowszycowa, Z.; Styś, K.; Straczkowski, W.; Woszczyk, A.; Straczkowska, B. 1972: The mathematical model of the electrical heart position in healthy patients and in heart hypertrophy Materia Medica Polona. Polish Journal of Medicine and Pharmacy 4(2): 60-65
Lehmann, K.; Giegler, I.; Rübesamen, M.; Grossmann, K.; Fink, R.; Schambach, H. 1973: Right heart hypertrophy of pulmonary heart disease in Frank's corrected orthogonal ECG Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 28(5): 147-153
Kim, M.H.; Yoo, D.S.; Lee, S.Y.; Byeon, S.E.; Lee, Y.G.; Min, T.; Rho, H.S.; Rhee, M.H.; Lee, J.; Cho, J.Y. 2011: The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects Die Pharmazie 66(4): 293-300
Luo, Y.; Liang, H.; Hu, C.; Xu, X.; Wang, Z. 2002: Decline in the expression of IL-2 after trauma and changes in the nuclear transcription factors NFAT and AP-1 Chinese Medical Journal 115(9): 1348-1351
Niesłuchowska, B.; Witkowski, J.; Marianowski, L.; Czerkwiński, J.; Kozłowski, W. 1980: Therapeutic procedures in pathologic endometrial hypertrophy Ginekologia Polska 51(8): 721-730
Key, N.S.; Bach, R.R. 2001: Tissue factor as a therapeutic target Thrombosis and Haemostasis 85(3): 375-376
Bierhaus, A.; Stern, D.M.; Nawroth, P.P. 2006: RAGE in inflammation: a new therapeutic target? Current Opinion in Investigational Drugs 7(11): 985-991
Kucińska, M.łg.; Piotrowska, H.; Murias, M. 2010: Sirtuins--modulation of their activity as a novel therapeutic target Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 28(165): 231-235
Mehta, H.; Busse, W.W. 1994: Eosinophil as a therapeutic target in allergic disease Comprehensive Therapy 20(11): 651-657
Halapas, A.; Diamanti-Kandarakis, E.; Kremastinos, D.; Koutsilieris, M. 2006: The PTHrP/PTH.1-R bioregulation system in cardiac hypertrophy: possible therapeutic implications In Vivo 20(6b): 837-844
Xie, Z.Z.; Liu, F.Y.; Wang, S.J.; Wan, Q.; Qiu, Y.F. 1996: Preventive and therapeutic effects of nitrendipine on hypoxic right ventricular hypertrophy Zhongguo Yao Li Xue Bao 17(4): 337-340